# Milestone Pharmaceuticals Inc. (MIST): MoatMap facts

As of 13 Nov 2026. Research data, not investment advice.

As of 13 Nov 2026, the MoatMap Score for Milestone Pharmaceuticals Inc. (MIST) is 1/100, ranked against 25,000+ stocks in 38 markets (Quality 17, Value 23, Momentum 17, each scored against its sector).

- MoatMap Score: 1/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 17, Value 23, Momentum 17: each a 0-100 percentile within Healthcare.
- Position: #26,359 overall, #2,618 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 0.6552 USD on 12 Nov 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/MIST
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker